HIV 1 News and Research

RSS

Many gay and bisexual men unaware that PrEP medication may reduce HIV risk

Only four in 10 gay and bisexual men in Baltimore without HIV are aware that pre-exposure prophylaxis medication (PrEP) may significantly reduce their risk of contracting the virus, even those who had recently visited a doctor or been tested for a sexually transmitted disease, new Johns Hopkins Bloomberg School of Public Health research suggests.

5 Oct 2016

Researchers confirm long persistence of Zika virus in semen and reveal its presence within spermatozoa

Recent work has shown that Zika virus persists in semen for up to 6 months after infection. In a correspondence published in The Lancet Infectious Diseases, the researchers, in addition to confirming its long persistence in semen (in this case for more than 130 days, i.e., over 4 months), reveal the presence of the virus even within spermatozoa.

4 Oct 2016

Antibody protection may help control infection caused by TB bacteria

A study led by investigators from the Ragon Institute of MGH, MIT and Harvard finds evidence that antibody protection may help control infection with the bacteria that causes tuberculosis (TB).

4 Oct 2016

Researchers move one step closer to developing effective universal flu vaccine

Researchers at McMaster University and two American universities have taken another step closer to developing a much more effective, "one-punch" universal flu vaccine.

4 Oct 2016

CCN article outlines unique treatment options for cardiovascular patients with HIV

Cardiovascular disease has become the leading cause of death for those living with HIV, as the infection has moved from a terminal disease to a chronic illness.

3 Oct 2016

New molecular biology technique could help identify virus-fighting potential of existing drugs

A new, computer-based screening method could reveal the virus-fighting potential of drugs originally developed to treat other conditions, reports a study in PLOS Computational Biology.

3 Oct 2016

Special issue of American Journal of Public Health explores impacts of Teen Pregnancy Prevention Program

A new supplement of the American Journal of Public Health out today explores the impacts of the U.S. Department of Health and Human Services' Office of Adolescent Health's Teen Pregnancy Prevention Program. This Journal issue contains expert commentary, research and recommendations based on outcomes from the program's implementation.

30 Sep 2016

Wayne State receives NIH funding to address health issues of HIV-positive and at-risk youth

A team of researchers led by Wayne State University has been awarded funding as a part of the Adolescent Medicine Trials Network for HIV/AIDS Interventions, a research network devoted to the health and well-being of adolescents and young adults with HIV or at risk for HIV infection.

28 Sep 2016

New project clarifies molecular processes involved in hidden HIV reservoir

In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect.

27 Sep 2016

Super-Resolution Imaging of Biological Specimens

In this interview, News Medical speaks to Dr. Manasa Gudheti of Bruker Nano Surfaces about biological specimens and how to acquire super-resolution images of them.

From Bruker Nano Surfaces and Metrology 27 Sep 2016

UNC secures $18 million NIH funding to form iTech for facilitating HIV research studies

People under the age of 30 account for the majority, or 40 percent, of new HIV infections in the United States.

26 Sep 2016

Broadly neutralizing HIV antibodies open new avenues for development of effective vaccine

A small number of people infected with HIV produce antibodies with an amazing effect: Not only are the antibodies directed against the own virus strain, but also against different sub-types of HIV that circulate worldwide.

26 Sep 2016

MU researcher awarded $3 million NIH grant to develop new drugs for treating HBV

Hepatitis B (HBV) is a viral infection that increases the likelihood of developing liver cancer or liver failure.

26 Sep 2016

Global study assesses countries on health-related Sustainable Development Goals

Worldwide, good progress has been made towards some of the health-related Sustainable Development Goals (SDGs) since 2000, particularly in reducing under-5 and neonatal mortality, family planning, and the rollout of universal health care.

24 Sep 2016

British Lung Foundation announces funding for IPF research

Britons are officially three times more likely to die of the incurable lung condition idiopathic pulmonary fibrosis (IPF), than in a road accident. Despite this, the disease is so unheard of and underfunded in research doctors still don’t know what causes it.

From Asthma + Lung UK 24 Sep 2016

World leaders at UN meeting commit to develop action plans on antimicrobial resistance

World leaders today signalled an unprecedented level of attention to curb the spread of infections that are resistant to antimicrobial medicines.

24 Sep 2016

Study provides insights into sexual health needs of bisexual teenage girls

Bisexual teenage girls are likely to miss out on the sexual healthcare information and services they need if healthcare providers present judgmental attitudes and assume patients' heterosexuality.

23 Sep 2016

Progesterone treatment protects female mice against consequences of influenza infection

Over 100 million women are on hormonal contraceptives. All of them contain some form of progesterone, either alone or in combination with estrogen.

22 Sep 2016

Solid-state NMR in structural biology: an interview with Professor Tatyana Polenova

My research lab studies several classes of systems. We are mostly interested in looking at large protein assemblies to understand their structure, dynamics and how their properties relate to their malfunction in disease.

From Bruker BioSpin Group 21 Sep 2016

New global health strategy aims to eliminate HCV as global public health threat by 2030

Chronic infection by the hepatitis C virus (HCV) proved fatal for over 700,000 people worldwide in 2013, mainly as a result of liver damage. Although information on the epidemiology of transmission and infection is sparse, recent estimates put the global prevalence of HCV infection at 130-150 million people.

21 Sep 2016

HIV 1 News and Research

Many gay and bisexual men unaware that PrEP medication may reduce HIV risk

Researchers confirm long persistence of Zika virus in semen and reveal its presence within spermatozoa

Antibody protection may help control infection caused by TB bacteria

Researchers move one step closer to developing effective universal flu vaccine

CCN article outlines unique treatment options for cardiovascular patients with HIV

New molecular biology technique could help identify virus-fighting potential of existing drugs

Special issue of American Journal of Public Health explores impacts of Teen Pregnancy Prevention Program

Wayne State receives NIH funding to address health issues of HIV-positive and at-risk youth

New project clarifies molecular processes involved in hidden HIV reservoir

Super-Resolution Imaging of Biological Specimens

UNC secures $18 million NIH funding to form iTech for facilitating HIV research studies

Broadly neutralizing HIV antibodies open new avenues for development of effective vaccine

MU researcher awarded $3 million NIH grant to develop new drugs for treating HBV

Global study assesses countries on health-related Sustainable Development Goals

British Lung Foundation announces funding for IPF research

World leaders at UN meeting commit to develop action plans on antimicrobial resistance

Study provides insights into sexual health needs of bisexual teenage girls

Progesterone treatment protects female mice against consequences of influenza infection

Solid-state NMR in structural biology: an interview with Professor Tatyana Polenova

New global health strategy aims to eliminate HCV as global public health threat by 2030

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News